BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 20619223)

  • 1. Differential diagnosis of hepatocellular carcinoma from metastatic tumors in the liver using microRNA expression.
    Barshack I; Meiri E; Rosenwald S; Lebanony D; Bronfeld M; Aviel-Ronen S; Rosenblatt K; Polak-Charcon S; Leizerman I; Ezagouri M; Zepeniuk M; Shabes N; Cohen L; Tabak S; Cohen D; Bentwich Z; Rosenfeld N
    Int J Biochem Cell Biol; 2010 Aug; 42(8):1355-62. PubMed ID: 20619223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma.
    Yamamoto Y; Kosaka N; Tanaka M; Koizumi F; Kanai Y; Mizutani T; Murakami Y; Kuroda M; Miyajima A; Kato T; Ochiya T
    Biomarkers; 2009 Nov; 14(7):529-38. PubMed ID: 19863192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of miR-122a and miR-224 expression in hepatocellular carcinoma by real-time fluorescence quantitative RT-PCR].
    Liu ZR; Chen XW; Qiao XH; Wang R; Xiang Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr; 29(4):751-3. PubMed ID: 19403413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deregulated expression of microRNA-221 with the potential for prognostic biomarkers in surgically resected hepatocellular carcinoma.
    Yoon SO; Chun SM; Han EH; Choi J; Jang SJ; Koh SA; Hwang S; Yu E
    Hum Pathol; 2011 Oct; 42(10):1391-400. PubMed ID: 21458843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Identification of metastasis-related microRNAs of hepatocellular carcinoma in hepatocellular carcinoma cell lines by quantitative real time PCR].
    Zhao Y; Jia HL; Zhou HJ; Dong QZ; Fu LY; Yan ZW; Sun J; Ren N; Ye QH; Qin LX
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):526-30. PubMed ID: 19912688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The relationship between microRNA-18 and BTG2 in the carcinogenesis of hepatocellular carcinoma].
    Li Q; Wang G; Zhang ZM
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):42-5. PubMed ID: 19203451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.
    Ladeiro Y; Couchy G; Balabaud C; Bioulac-Sage P; Pelletier L; Rebouissou S; Zucman-Rossi J
    Hepatology; 2008 Jun; 47(6):1955-63. PubMed ID: 18433021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma.
    Li LM; Hu ZB; Zhou ZX; Chen X; Liu FY; Zhang JF; Shen HB; Zhang CY; Zen K
    Cancer Res; 2010 Dec; 70(23):9798-807. PubMed ID: 21098710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.
    Liu WH; Yeh SH; Lu CC; Yu SL; Chen HY; Lin CY; Chen DS; Chen PJ
    Gastroenterology; 2009 Feb; 136(2):683-93. PubMed ID: 19027010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma.
    Li Y; Tan W; Neo TW; Aung MO; Wasser S; Lim SG; Tan TM
    Cancer Sci; 2009 Jul; 100(7):1234-42. PubMed ID: 19486339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [MicroRNA profiling in patients with hepatocellular carcinoma].
    Wang CX; Song W; Li ZJ; Song B; Wu DH; Sun AM; Chen LH
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):976-7. PubMed ID: 20501372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
    J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: its potential use in the diagnosis of liver neoplasms.
    Abe N; Watanabe T; Izumisato Y; Suzuki Y; Masaki T; Mori T; Sugiyama M; Fusco A; Atomi Y
    J Gastroenterol; 2003; 38(12):1144-9. PubMed ID: 14714251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance.
    Karakatsanis A; Papaconstantinou I; Gazouli M; Lyberopoulou A; Polymeneas G; Voros D
    Mol Carcinog; 2013 Apr; 52(4):297-303. PubMed ID: 22213236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating microRNAs as biomarkers for hepatocellular carcinoma.
    Qu KZ; Zhang K; Li H; Afdhal NH; Albitar M
    J Clin Gastroenterol; 2011 Apr; 45(4):355-60. PubMed ID: 21278583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
    Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S
    FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA expression differentiates between primary lung tumors and metastases to the lung.
    Barshack I; Lithwick-Yanai G; Afek A; Rosenblatt K; Tabibian-Keissar H; Zepeniuk M; Cohen L; Dan H; Zion O; Strenov Y; Polak-Charcon S; Perelman M
    Pathol Res Pract; 2010 Aug; 206(8):578-84. PubMed ID: 20418022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development.
    Shigoka M; Tsuchida A; Matsudo T; Nagakawa Y; Saito H; Suzuki Y; Aoki T; Murakami Y; Toyoda H; Kumada T; Bartenschlager R; Kato N; Ikeda M; Takashina T; Tanaka M; Suzuki R; Oikawa K; Takanashi M; Kuroda M
    Pathol Int; 2010 May; 60(5):351-7. PubMed ID: 20518884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic identification of microRNA-122a target proteins in hepatocellular carcinoma.
    Diao S; Zhang JF; Wang H; He ML; Lin MC; Chen Y; Kung HF
    Proteomics; 2010 Oct; 10(20):3723-31. PubMed ID: 20859956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of microRNA expression profiling identifies microRNA-503 regulates metastatic function in hepatocellular cancer cell.
    Zhou J; Wang W
    J Surg Oncol; 2011 Sep; 104(3):278-83. PubMed ID: 21495032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.